Adebellizumab

DRUG2 trials

Sponsors

Zhejiang University, The First Affiliated Hospital of Guangzhou Medical University

Conditions

Neoadjuvant ChemotherapyResectable Lung Non-Small Cell CarcinomaResectable Pancreatic Cancer

Phase 2

Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab

Not yet recruitingNCT06172036

Zhejiang UniversityNeoadjuvant Chemotherapy, Resectable Pancreatic Cancer

Start: 2024-01-20End: 2027-01-20Target: 180Updated: 2023-12-15

A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

RecruitingNCT06775275

The First Affiliated Hospital of Guangzhou Medical UniversityResectable Lung Non-Small Cell Carcinoma

Start: 2024-09-24End: 2029-12-31Target: 60Updated: 2025-01-15